MOUNTAIN VIEW, Calif, March 2, 2010 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS), a biopharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today announced that it will report financial results for the fourth quarter and year ended December 31, 2009 after the NASDAQ Market closes on Monday, March 8, 2010.
